APA (7th ed.) Citation

Guo, Y., Zhou, X., Xu, H., & Wang, G. (2025). SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-25096-z

Chicago Style (17th ed.) Citation

Guo, Yuan, Xiaoli Zhou, Haoran Xu, and Gengfang Wang. "SEPT9 Methylation as a Diagnostic and Predictive Biomarker in the Progression of Ductal Carcinoma in Situ to Invasive Breast Cancer." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-25096-z.

MLA (9th ed.) Citation

Guo, Yuan, et al. "SEPT9 Methylation as a Diagnostic and Predictive Biomarker in the Progression of Ductal Carcinoma in Situ to Invasive Breast Cancer." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-25096-z.